PRP for knee osteoarthritis: placebo-controlled trials still disagree
Large and newer placebo-controlled PRP trials report different symptom and MRI results. Preparation methods and primary outcomes explain why certainty remains limited.

PRP remains difficult to judge because placebo-controlled trials use different preparations and report conflicting symptom and structural findings.
Your own blood can still produce a variable treatment
Platelet-rich plasma sounds standardized because it starts with a patient’s blood. In practice, centrifugation, platelet concentration, white-cell content, activation, injection number and timing can all differ. That variability helps explain why one PRP headline may not predict another clinic’s result.
The problem resembles the negative bromelain placebo trial: a result from one defined preparation cannot validate every treatment carrying the same category name. For PRP, the clinic protocol is part of the intervention.
The RESTORE trial found no meaningful advantage
The 2021 RESTORE trial randomized 288 adults with mild-to-moderate medial knee osteoarthritis to three weekly PRP or saline injections. At 12 months, PRP did not produce a significant improvement in pain or medial tibial cartilage volume compared with placebo.
This was a large, blinded, placebo-controlled study with symptom and structural outcomes. It weighs heavily against broad promises that PRP reliably relieves pain or preserves cartilage. It does not prove that every protocol is ineffective, but it raises the standard for positive claims.

A 2025 MRI trial reported a more favorable pattern
A newer randomized double-blind trial compared single-spin PRP, double-spin PRP and saline over six months. The authors reported favorable differences for several pain, function and MRI measures in the PRP groups, while osteophytes and subchondral cyst findings did not clearly differ.
The result deserves attention, but one smaller study does not erase RESTORE. Different protocols, populations, analysis plans and follow-up can change the answer. The MSM knee-osteoarthritis guide likewise keeps a promising signal separate from a settled treatment conclusion.
Ask the clinic for the protocol, not a slogan
Before paying, ask how many injections are recommended, whether the product is leukocyte-rich or leukocyte-poor, how platelets are measured, what evidence supports that protocol, and what total cost includes. Request the clinician’s expected timeline and a plan if symptoms do not improve.
Also ask about infection precautions, anticoagulants, anemia, blood disorders and post-procedure activity. PRP is a medical procedure, not a food supplement. Eligibility and risk depend on the person and the practice, and insurance coverage can vary.

Pain relief and cartilage change must remain separate
A person may value pain relief even if imaging does not change. Conversely, an MRI measurement can shift without producing a noticeable improvement in daily life. Trials should state a primary outcome so readers are not invited to choose whichever secondary result sounds best afterward.
The pine-bark knee evidence also shows why symptom findings cannot by themselves prove cartilage rebuilding. Words such as regenerative or healing should not replace direct, durable structural evidence tied to better patient outcomes.
Make the decision with uncertainty visible
PRP may remain reasonable to discuss after diagnosis, exercise therapy and established options have been reviewed, especially when a clinician explains the protocol and uncertainty clearly. It should not be sold as a guaranteed way to avoid surgery or regrow a normal joint surface.
Define success before the first injection, use a repeatable pain and function measure, and set a review date. The current research contains both negative and favorable placebo-controlled results. Conflicting trials are not a reason for panic or hype; they are a reason to demand precise information before accepting a costly procedure. The guide to reading a joint supplement trial explains why planned comparisons and outcomes shape the conclusion.
Cost and follow-up deserve the same scrutiny
PRP is often paid for out of pocket, and clinics may recommend different numbers of injections. Request the full price, follow-up schedule and cancellation terms in writing. Ask whether additional imaging, braces or rehabilitation are separate costs and whether unused visits are refundable.
A high price is not evidence of a stronger preparation. Compare the clinic’s claims with the exact placebo-controlled protocol it cites. If the marketing promises guaranteed regeneration, a permanent result or a precise success rate without a matching source, that is a reason to slow down.
Keep copies of consent forms, preparation details and procedure notes. If another clinician later reviews the knee, those records show what was injected, when it was given and how the joint responded.